help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qasim, F. J.
Right arrow Articles by Oliveira, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qasim, F. J.
Right arrow Articles by Oliveira, D. B.

American Journal of Pathology, Vol 149, 81-89, Copyright © 1996 by American Society for Investigative Pathology


REGULAR ARTICLES

Role of neutrophils in the pathogenesis of experimental vasculitis

FJ Qasim, PW Mathieson, F Sendo, S Thiru and DB Oliveira
Department of Medicine, University of Cambridge, United Kingdom.

In the Brown-Norway rat, mercuric chloride (HgCl2) induces an autoimmune syndrome characterized by high IgE levels. There is widespread necrotizing leukocytoclastic vasculitis involving lung, skin, mucous membranes, pancreas, liver, and gut, with tissue injury being most marked in the cecum. As in systemic vasculitis in man, there are neutrophils at the site of tissue injury and the animals develop anti-neutrophil cytoplasmic antibodies, which in the Brown-Norway rat are directed against myeloperoxidase. To determine whether neutrophils are involved in the pathogenesis of the vasculitis, we have used a monoclonal antibody that was reported to deplete neutrophils in other rat strains. Rats treated with HgCl2 received antibody by intravenous injection at various time points. Serial blood samples were taken for neutrophil counts and to assay for anti-myeloperoxidase and IgE antibodies. The guts of animals killed after antibody therapy were scored for vasculitic changes and neutrophils infiltrate. RP3 (but not the control antibody MAC6) was shown to bind to Brown-Norway rat neutrophils and to block glycogen-induced influx of neutrophils into the peritoneum. When given at peak disease, RP3 caused a dose-dependent reduction in tissue injury with a marked reduction in circulating blood neutrophil numbers and in tissue neutrophil infiltrate. RP3 treatment did not affect the rise in titer of IgE and anti-myeloperoxidase antibodies. The data presented demonstrate that in this model neutrophils are necessary for the induction of vasculitis and that the degree of vasculitis correlates with neutrophil number. To our knowledge, this study is the first to provide direct evidence for a role for neutrophils in vasculitis. We suggest that antibodies directed against neutrophils, especially if they deplete neutrophils, may be useful in the therapy of vasculitis in man.


This article has been cited by other articles:


Home page
J. Exp. Med.Home page
L. Bennett, A. K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
J. Exp. Med., March 17, 2003; 197(6): 711 - 723.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. KETTRITZ, A. SCHREIBER, F. C. LUFT, and H. HALLER
Role of Mitogen-Activated Protein Kinases in Activation of Human Neutrophils by Antineutrophil Cytoplasmic Antibodies
J. Am. Soc. Nephrol., January 1, 2001; 12(1): 37 - 46.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. SCHNABEL, E. CSERNOK, J. BRAUN, and W. L. GROSS
Activation of Neutrophils, Eosinophils, and Lymphocytes in the Lower Respiratory Tract in Wegener's Granulomatosis
Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 399 - 405.
[Abstract] [Full Text]


Home page
LupusHome page
K de Groot and W L Gross
Wegener's granulomatosis: disease course, assessment of activity and extent and treatment
Lupus, May 1, 1998; 7(4): 285 - 291.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society for Investigative Pathology.